Skip to main content
Clinical Trials/NCT03712189
NCT03712189
Completed
Not Applicable

The Utility of LifeFlow Rapid Fluid Infuser in Critical and Non-critical Pediatric Patients: a Mixed-method Pilot Study Protocol

Children's Hospital Los Angeles1 site in 1 country30 target enrollmentOctober 2, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Dehydration in Children
Sponsor
Children's Hospital Los Angeles
Enrollment
30
Locations
1
Primary Endpoint
Duration- Ultrasound Ordered to Completed
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This is an unblinded, randomized control study examining two fluid delivery modalities for non-critical female patients with a planned transabdominal pelvic ultrasound requiring intravenous fluid boluses.

Detailed Description

Subjects be identified during their clinical course in the ED and will be randomized to either the LifeFlow® fluid delivery or an IV fluid bolus through the Alaris® pump (standard of care). IV fluids will be provided until the subject notes the sensation of a full bladder, at which point, the standard of care clinical practice is to perform the ultrasound. The transabdominal pelvic ultrasound requires a full bladder for optimal visualization of the ovaries, adnexa, and uterus, and is the only alternative to a transvaginal pelvic ultrasound for virginal young women. All other clinical care is per standard of care. The only research component is the randomization and data collection.

Registry
clinicaltrials.gov
Start Date
October 2, 2018
End Date
June 30, 2019
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Todd P Chang, MD MAcM

Principal Investigator

Children's Hospital Los Angeles

Eligibility Criteria

Inclusion Criteria

  • Female patients older than 1 month and less than 18 years
  • Patients require IV crystalloid bolus fluids before a pelvic ultrasound

Exclusion Criteria

  • Known cardiac insufficiency or significant cardiac surgery
  • Hepatic insufficiency
  • Renal insufficiency
  • Any known fluid overload states (ascites, pulmonary edema)
  • On any diuretic or antihypertensive therapy
  • Known pregnancy

Outcomes

Primary Outcomes

Duration- Ultrasound Ordered to Completed

Time Frame: From ED (Emergency Department) arrival to discharge/admission, less than 12 hours

The primary outcome variable is the duration (minutes) of time from when the ultrasound was ordered to the completion time of the ultrasound.

Secondary Outcomes

  • Total IV Fluid (mL)(From ED arrival to discharge/admission, less than 12 hours)
  • Duration- Full Bladder(From ED arrival to discharge/admission, less than 12 hours)

Study Sites (1)

Loading locations...

Similar Trials